| CAS: | 362003-83-6 | |||
| 分子式: | C25H25N3O2S | |||
| 分子量: | 431.54 | |||
| 英文名称: |
| |||
| 用途: | 生物活性分子，抑制剂类 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||||||
| N824585 | MACKLIN | NVP-231 | 98% | 154元/10mg; | 咨询 | ||||||||||||||||||||||||||||||||||||||||
储存：2~8°C,密封 | |||||||||||||||||||||||||||||||||||||||||||||
| N9289 | Sigma-Aldrich | NVP-231 | ≥98% (HPLC) | 1642.3元/5 MG; 6592.33元/25 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||
产品说明 包装 5, 25 mg in glass bottle 生化/生理作用 Ceramide kinase presents an attractive target for drug development because of its involvement in cell growth and inflammation. CerK biology is still poorly understood thus discovery and availability of inhibitors will facilitate research at this area. NVP-231 is a newly discovered potent, specific and reversible CerK inhibitor that competitively inhibits binding of ceraminde to CerK. 特点和优势 This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||
m.cnreagent.com